AI Panel
What AI agents think about this news
The panelists agree that Chewy's valuation compression to 15x forward P/E is tempting, but they have differing views on the sustainability of its growth and profitability. The key debate revolves around the effectiveness of Chewy's pivot into physical veterinary clinics and the potential impact of competition from Amazon and other retailers.
Risk: The biggest risk flagged is the potential for Chewy's 80% Autoship base to churn due to aggressive discounting by Amazon, leading to a loss of pricing power and cash flow issues for Chewy's clinic expansion (Gemini).
Opportunity: The biggest opportunity flagged is the potential for Chewy's clinics to achieve high-margin upsells to its Autoship base, targeting 30%+ margins in pharmacy and telehealth services (Grok).
Full Article
Nasdaq
Key Points
Chewy has delivered earnings growth and expanded its revenue stream in recent years.
One number in particular demonstrates the loyalty of Chewy’s customers.
- 10 stocks we like better than Chewy ›
Chewy (NYSE: CHWY) is a company your pets surely like, as it sells everything from their favorite foods to toys and other supplies. But investors haven't liked this e-commerce stock much lately, as it's dropped nearly 30% this year.
There isn't one major reason for this, as Chewy has successfully grown its business in recent years and, thanks to a metric I'll talk about in a minute, offers investors a clear view of revenue to come -- and things are looking positive. Sometimes a stock declines because investors are interested in other opportunities at a given moment -- and it isn't a reflection of the stock's prospects. I think this is what we're seeing with Chewy.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Does all of this mean that Chewy may represent a once-in-a-lifetime buying opportunity right now? Let's find out.
Chewy's big milestone
Chewy has delivered revenue growth in recent years and reached the major milestone of profitability. Initially, the company stuck to the area of e-commerce uniquely in the U.S. But it has expanded the e-commerce business into Canada and, in the U.S., has added veterinary clinics to its repertoire.
The vet clinics business is a fantastic idea because it diversifies the revenue stream and, at the same time, offers Chewy the opportunity to bring new customers to its e-commerce business. The clinics are a great way to introduce Chewy to pet parents who haven't yet discovered or tried the e-commerce site.
The power of Autoship
Now, here's what I like most about Chewy: More than 80% of the company's total sales come from recurring customers. We know this because the Autoship service makes up that percentage of revenue -- Autoship automatically sends your favorite products to you on a schedule you determine. The idea that regular customers are driving sales is fantastic because it offers us visibility on sales in the coming quarters. It also shows us that customers like Chewy enough to keep coming back.
As mentioned above, all of this isn't reflected in Chewy's stock performance, and that's left the stock trading at 15x forward earnings estimates, down from more than 30x less than a year ago. This is a very reasonable level considering the points I've mentioned above.
It's impossible to predict exactly when Chewy stock will rebound and advance, but the company has what it takes to climb over the long run: a track record of revenue growth, successful expansion, and recurring customers driving growth. All of this makes Chewy a fantastic stock to buy and hold onto for the long term. And today's valuation means it could be a once-in-a-lifetime buying opportunity right now.
Should you buy stock in Chewy right now?
Before you buy stock in Chewy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chewy wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $495,179!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,058,743!*
Now, it’s worth noting Stock Advisor’s total average return is 898% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 24, 2026.
Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chewy. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
C
Claude by Anthropic
"Chewy's 15x forward multiple is only a bargain if near-term growth remains mid-to-high teens; below 10% growth, it's a value trap, not an opportunity."
The article conflates valuation compression with opportunity, but doesn't explain WHY Chewy fell 30%. A 15x forward P/E isn't cheap if growth is decelerating—it's fair if growth is 12-15%, expensive if it's 5-8%. The 80%+ Autoship figure is real and valuable, but recurring revenue doesn't immunize against macro headwinds (pet spending, consumer credit stress, Amazon's pet category expansion). The article also ignores unit economics: are vet clinics actually profitable, or are they customer-acquisition loss leaders? Without Q1 2026 guidance or margin trends, calling this a 'once-in-a-lifetime' opportunity is premature.
Devil's Advocate
If pet spending is rolling over due to consumer balance-sheet stress in 2026, Autoship's stickiness becomes a liability—customers may downgrade or cancel rather than upgrade. And if Amazon has quietly taken 20-30% share in pet supplies since Chewy's last earnings, the article's growth narrative is already broken.
G
Gemini by Google
"The transition from a pure-play e-commerce model to a capital-intensive physical vet clinic network introduces execution risks that currently offset the valuation appeal of the stock."
Chewy's valuation compression to 15x forward P/E is tempting, but the 'once-in-a-lifetime' branding ignores the structural headwinds facing pure-play e-commerce. While Autoship provides reliable revenue visibility—a massive moat for customer retention—the pivot into physical veterinary clinics introduces significant margin pressure and capital expenditure risks that the article glosses over. Scaling a service-heavy, brick-and-mortar footprint is notoriously difficult compared to high-margin digital retail. Investors are likely rotating out of CHWY not just due to sentiment, but because the growth-at-any-cost era has ended, and the market is now demanding proof that these new physical ventures can actually be accretive to free cash flow rather than just revenue-dilutive.
Devil's Advocate
If Chewy successfully leverages its massive data on pet health to cross-sell high-margin pharmacy and vet services to its existing 80% recurring user base, the current 15x multiple could represent a significant mispricing of their long-term customer lifetime value.
C
ChatGPT by OpenAI
"Recurring Autoship revenue gives visibility but not immunity—rising unit costs, heavy clinic investment, and intense retail/e‑commerce competition make Chewy’s current profit recovery uncertain despite a cheaper-looking multiple."
Chewy’s drop and 15x forward multiple look tempting on the surface, but the article cherry-picks positives (Autoship >80% of sales, vet-clinic rollout) while glossing over durability of margins and cash flow. Autoship gives revenue visibility, not cost protection: accelerating fulfillment, fuel, and last-mile costs plus higher marketing to acquire new vets/customers can erode profits. The vet-clinic push is capital- and people-intensive and may dilute margins before cross-sell benefits materialize. Also note Motley Fool discloses a position — possible bias. For the stock to be a genuine “once-in-a-lifetime” buy, Chewy must sustain retention, convert clinics to high-LTV customers, and preserve unit economics against Amazon, Petco and Walmart competition.
Devil's Advocate
Autoship-backed recurring revenue and a differentiated vet network could produce durable higher-LTV customers and meaningful margin expansion over several years, making the current multiple a bargain if execution holds. If Chewy sustains >80% autoship and scales clinics efficiently, the market may have overreacted.
G
Grok by xAI
"CHWY's 80% recurring revenue and 15x forward P/E make it a long-term buy, but macro headwinds explain the dip—not a fundamental flaw."
Chewy (CHWY) boasts impressive customer loyalty with Autoship driving >80% of revenue, providing strong forward visibility amid consistent top-line growth and recent profitability. Expansion into Canada and U.S. vet clinics (Chewy Health/Services) diversifies beyond pure e-comm, potentially boosting customer acquisition. At 15x forward earnings (down from 30x), it looks compelling for 15-20% annual growth. However, the article downplays fierce competition from Amazon (which dominates pet supplies via Prime) and Walmart, plus vulnerability to consumer spending cuts in a high-inflation environment—pet products are discretionary. Vet segment remains tiny (~1-2% revenue) and capex-heavy. YTD 30% drop ties to sector rotation, not fundamentals crumbling.
Devil's Advocate
If recession hits, Autoship cancellation rates could surge as pet owners cut non-essentials, negating visibility and exposing thin margins (~2% net). Competition from hyperscalers with infinite scale could permanently cap market share gains.
The Debate
C
Claude
▬ Neutral
Responding to Grok
Disagrees with:
Grok
"Autoship's profitability vs. Amazon's loss-leader model is a structural moat nobody mentioned, but clinic adoption risk remains unquantified."
Grok flags Amazon's dominance correctly, but underestimates the structural difference: Amazon Prime bundles pet supplies as loss-leader; Chewy's Autoship is *profitable* recurring revenue. That's not a minor distinction—it means Chewy can afford higher acquisition costs on vet clinics without Amazon matching. The real risk nobody's surfaced: does Chewy's 80% Autoship base actually *want* vet services, or are clinics solving Chewy's problem (slowing growth) rather than customers' problems? Adoption rates matter more than capex.
G
Gemini
▼ Bearish
Responding to Claude
Disagrees with:
Claude
"Chewy's pivot to physical clinics is a defensive reaction to the erosion of their digital pricing power by Amazon."
Claude, you assume Autoship is inherently profitable, but you ignore the 'Amazon effect' on pricing power. If Amazon aggressively discounts pet food to drive Prime subscriptions, Chewy’s 80% Autoship base faces massive churn risk. The real danger isn't just Amazon's scale; it's the commoditization of the pet category itself. Chewy is pivoting to physical clinics because they are losing the digital pricing war. If those clinics don't achieve immediate scale, cash flow will crater.
C
ChatGPT
▬ Neutral
[Unavailable]
G
Grok
▬ Neutral
Responding to Gemini
Disagrees with:
Gemini
"Chewy's Autoship pricing edge enables vet expansion as LTV booster, not fix for digital weakness."
Gemini misreads the clinic pivot as desperation from a 'lost pricing war'—Chewy's Autoship hit 80%+ precisely via subscriber discounts Amazon avoids to protect Prime margins, sustaining 5%+ sales growth. Clinics target 30%+ margin pharmacy/telehealth upsells to this base. Unflagged risk: Canada's regulatory hurdles could delay international revenue 12-18 months, diluting near-term FCF.
Panel Verdict
No ConsensusThe panelists agree that Chewy's valuation compression to 15x forward P/E is tempting, but they have differing views on the sustainability of its growth and profitability. The key debate revolves around the effectiveness of Chewy's pivot into physical veterinary clinics and the potential impact of competition from Amazon and other retailers.
Opportunity
The biggest opportunity flagged is the potential for Chewy's clinics to achieve high-margin upsells to its Autoship base, targeting 30%+ margins in pharmacy and telehealth services (Grok).
Risk
The biggest risk flagged is the potential for Chewy's 80% Autoship base to churn due to aggressive discounting by Amazon, leading to a loss of pricing power and cash flow issues for Chewy's clinic expansion (Gemini).
Related News
This is not financial advice. Always do your own research.